| Literature DB >> 29461645 |
Katja Hartstock1, Benedikt S Nilges2, Anna Ovcharenko1, Nicolas V Cornelissen1, Nikolai Püllen1, Ann-Marie Lawrence-Dörner1, Sebastian A Leidel2, Andrea Rentmeister1.
Abstract
m6 A is the most abundant internal modification in eukaryotic mRNA. It is introduced by METTL3-METTL14 and tunes mRNA metabolism, impacting cell differentiation and development. Precise transcriptome-wide assignment of m6 A sites is of utmost importance. However, m6 A does not interfere with Watson-Crick base pairing, making polymerase-based detection challenging. We developed a chemical biology approach for the precise mapping of methyltransferase (MTase) target sites based on the introduction of a bioorthogonal propargyl group in vitro and in cells. We show that propargyl groups can be introduced enzymatically by wild-type METTL3-METTL14. Reverse transcription terminated up to 65 % at m6 A sites after bioconjugation and purification, hence enabling detection of METTL3-METTL14 target sites by next generation sequencing. Importantly, we implemented metabolic propargyl labeling of RNA MTase target sites in vivo based on propargyl-l-selenohomocysteine and validated different types of known rRNA methylation sites.Entities:
Keywords: N6-methyladenosine; RNA; metabolic labeling; ribose methylation; transferases
Year: 2018 PMID: 29461645 DOI: 10.1002/anie.201800188
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336